Article
Publicly Available
Frontmatter
Published/Copyright:
December 20, 2021
Published Online: 2021-12-20
©2021 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Research Articles
- Consensus statement on safety measures for pressurized intraperitoneal aerosol chemotherapy
- Can pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-O+) be added to standard treatment for resectable high-risk gastric cancer patients? A study protocol
- Risk factors and clinical outcomes in patients undergoing cytoreductive surgery with concomitant ureteric reimplantation
- Characteristics of early pleural effusions after orthotopic heart transplantation: comparison with coronary artery bypass graft surgery
- Short Communication
- Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report
Articles in the same Issue
- Frontmatter
- Research Articles
- Consensus statement on safety measures for pressurized intraperitoneal aerosol chemotherapy
- Can pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-O+) be added to standard treatment for resectable high-risk gastric cancer patients? A study protocol
- Risk factors and clinical outcomes in patients undergoing cytoreductive surgery with concomitant ureteric reimplantation
- Characteristics of early pleural effusions after orthotopic heart transplantation: comparison with coronary artery bypass graft surgery
- Short Communication
- Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report